Global and Region Integrin Alpha 4 Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The report details the trend, potential and market size of Integrin Alpha 4 market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Integrin Alpha 4market, defines the market attractiveness level of Integrin Alpha 4 market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Integrin Alpha 4 industry, describes the types of Integrin Alpha 4 market, the applications of major players and the market size, and deeply analyzes the current situation of the global Integrin Alpha 4 market and the development prospects and opportunities of Integrin Alpha 4 industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Integrin Alpha 4 market in Chapter 13.

    By Player:

    • Takeda Pharmaceutical Co Ltd

    • Viriom Inc

    • Antisense Therapeutics Ltd

    • Morphic Therapeutic Inc

    • Amgen Inc

    • Daiichi Sankyo Co Ltd

    • Protagonist Therapeutics Inc

    • Biogen Inc

    • Immunwork Inc

    • EA Pharma Co Ltd

    • BioMAS Ltd

    By Type:

    • TE-5232

    • ATL-1102

    • Carotegrast

    • ET-3764

    • Others

    By End-User:

    • Acute Ischemic Stroke

    • Celiac Disease

    • Epilepsy

    • Melanoma

    • Multiple Sclerosis

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Integrin Alpha 4 Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Integrin Alpha 4 Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Integrin Alpha 4 Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Integrin Alpha 4 Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Integrin Alpha 4 Market Analysis and Outlook to 2022

    • 7.1 Global Integrin Alpha 4 Consumption (2017-2022)

    • 7.2 United States Integrin Alpha 4 Consumption (2017-2022)

    • 7.3 Europe Integrin Alpha 4 Consumption (2017-2022)

    • 7.4 China Integrin Alpha 4 Consumption (2017-2022)

    • 7.5 Japan Integrin Alpha 4 Consumption (2017-2022)

    • 7.6 India Integrin Alpha 4 Consumption (2017-2022)

    • 7.7 South Korea Integrin Alpha 4 Consumption (2017-2022)

    8 Region and Country-wise Integrin Alpha 4 Market Analysis and Outlook to 2028

    • 8.1 Global Integrin Alpha 4 Consumption Forecast (2022-2028)

    • 8.2 United States Integrin Alpha 4 Consumption Forecast (2022-2028)

    • 8.3 Europe Integrin Alpha 4 Consumption Forecast (2022-2028)

    • 8.4 China Integrin Alpha 4 Consumption Forecast (2022-2028)

    • 8.5 Japan Integrin Alpha 4 Consumption Forecast (2022-2028)

    • 8.6 India Integrin Alpha 4 Consumption Forecast (2022-2028)

    • 8.7 South Korea Integrin Alpha 4 Consumption Forecast (2022-2028)

    9 Global Integrin Alpha 4 Market Outlook by Types and Applications to 2022

    • 9.1 Global Integrin Alpha 4 Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global TE-5232 Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global ATL-1102 Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Carotegrast Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global ET-3764 Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Integrin Alpha 4 Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Acute Ischemic Stroke Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Celiac Disease Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Epilepsy Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Melanoma Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Multiple Sclerosis Consumption and Growth Rate (2017-2022)

      • 9.2.6 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Integrin Alpha 4 Market Outlook by Types and Applications to 2028

    • 10.1 Global Integrin Alpha 4 Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global TE-5232 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global ATL-1102 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Carotegrast Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global ET-3764 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Integrin Alpha 4 Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Acute Ischemic Stroke Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Celiac Disease Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Epilepsy Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Melanoma Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Multiple Sclerosis Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.6 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Integrin Alpha 4 Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Integrin Alpha 4 Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Integrin Alpha 4 Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Integrin Alpha 4 Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Integrin Alpha 4 Market Competitive Analysis

    • 14.1 Takeda Pharmaceutical Co Ltd

      • 14.1.1 Takeda Pharmaceutical Co Ltd Company Details

      • 14.1.2 Takeda Pharmaceutical Co Ltd Integrin Alpha 4 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Takeda Pharmaceutical Co Ltd Integrin Alpha 4 Product and Service

    • 14.2 Viriom Inc

      • 14.2.1 Viriom Inc Company Details

      • 14.2.2 Viriom Inc Integrin Alpha 4 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Viriom Inc Integrin Alpha 4 Product and Service

    • 14.3 Antisense Therapeutics Ltd

      • 14.3.1 Antisense Therapeutics Ltd Company Details

      • 14.3.2 Antisense Therapeutics Ltd Integrin Alpha 4 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Antisense Therapeutics Ltd Integrin Alpha 4 Product and Service

    • 14.4 Morphic Therapeutic Inc

      • 14.4.1 Morphic Therapeutic Inc Company Details

      • 14.4.2 Morphic Therapeutic Inc Integrin Alpha 4 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Morphic Therapeutic Inc Integrin Alpha 4 Product and Service

    • 14.5 Amgen Inc

      • 14.5.1 Amgen Inc Company Details

      • 14.5.2 Amgen Inc Integrin Alpha 4 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Amgen Inc Integrin Alpha 4 Product and Service

    • 14.6 Daiichi Sankyo Co Ltd

      • 14.6.1 Daiichi Sankyo Co Ltd Company Details

      • 14.6.2 Daiichi Sankyo Co Ltd Integrin Alpha 4 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Daiichi Sankyo Co Ltd Integrin Alpha 4 Product and Service

    • 14.7 Protagonist Therapeutics Inc

      • 14.7.1 Protagonist Therapeutics Inc Company Details

      • 14.7.2 Protagonist Therapeutics Inc Integrin Alpha 4 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Protagonist Therapeutics Inc Integrin Alpha 4 Product and Service

    • 14.8 Biogen Inc

      • 14.8.1 Biogen Inc Company Details

      • 14.8.2 Biogen Inc Integrin Alpha 4 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Biogen Inc Integrin Alpha 4 Product and Service

    • 14.9 Immunwork Inc

      • 14.9.1 Immunwork Inc Company Details

      • 14.9.2 Immunwork Inc Integrin Alpha 4 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Immunwork Inc Integrin Alpha 4 Product and Service

    • 14.10 EA Pharma Co Ltd

      • 14.10.1 EA Pharma Co Ltd Company Details

      • 14.10.2 EA Pharma Co Ltd Integrin Alpha 4 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 EA Pharma Co Ltd Integrin Alpha 4 Product and Service

    • 14.11 BioMAS Ltd

      • 14.11.1 BioMAS Ltd Company Details

      • 14.11.2 BioMAS Ltd Integrin Alpha 4 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 BioMAS Ltd Integrin Alpha 4 Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Integrin Alpha 4

    • Figure Integrin Alpha 4 Picture

    • Table Global Integrin Alpha 4 Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Integrin Alpha 4 Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Integrin Alpha 4 Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Integrin Alpha 4 Consumption by Country (2017-2022)

    • Figure United States Integrin Alpha 4 Consumption and Growth Rate (2017-2022)

    • Table Europe Integrin Alpha 4 Consumption and Growth Rate (2017-2022)

    • Figure China Integrin Alpha 4 Consumption and Growth Rate (2017-2022)

    • Figure Japan Integrin Alpha 4 Consumption and Growth Rate (2017-2022)

    • Figure India Integrin Alpha 4 Consumption and Growth Rate (2017-2022)

    • Figure South Korea Integrin Alpha 4 Consumption and Growth Rate (2017-2022)

    • Figure Global Integrin Alpha 4 Consumption Forecast by Country (2022-2028)

    • Figure United States Integrin Alpha 4 Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Integrin Alpha 4 Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Integrin Alpha 4 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Integrin Alpha 4 Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Integrin Alpha 4 Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Integrin Alpha 4 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global TE-5232 Consumption and Growth Rate (2017-2022)

    • Figure Global ATL-1102 Consumption and Growth Rate (2017-2022)

    • Figure Global Carotegrast Consumption and Growth Rate (2017-2022)

    • Figure Global ET-3764 Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Acute Ischemic Stroke Consumption and Growth Rate (2017-2022)

    • Figure Global Celiac Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Epilepsy Consumption and Growth Rate (2017-2022)

    • Figure Global Melanoma Consumption and Growth Rate (2017-2022)

    • Figure Global Multiple Sclerosis Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global TE-5232 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global ATL-1102 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Carotegrast Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global ET-3764 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Acute Ischemic Stroke Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Celiac Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Epilepsy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Melanoma Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Multiple Sclerosis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Integrin Alpha 4 Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Integrin Alpha 4 Export by Region (Top 5 Countries) (2017-2028)

    • Table Takeda Pharmaceutical Co Ltd (Foundation Year, Company Profile and etc.)

    • Table Takeda Pharmaceutical Co Ltd Integrin Alpha 4 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Takeda Pharmaceutical Co Ltd Integrin Alpha 4 Product and Service

    • Table Viriom Inc (Foundation Year, Company Profile and etc.)

    • Table Viriom Inc Integrin Alpha 4 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Viriom Inc Integrin Alpha 4 Product and Service

    • Table Antisense Therapeutics Ltd (Foundation Year, Company Profile and etc.)

    • Table Antisense Therapeutics Ltd Integrin Alpha 4 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Antisense Therapeutics Ltd Integrin Alpha 4 Product and Service

    • Table Morphic Therapeutic Inc (Foundation Year, Company Profile and etc.)

    • Table Morphic Therapeutic Inc Integrin Alpha 4 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Morphic Therapeutic Inc Integrin Alpha 4 Product and Service

    • Table Amgen Inc (Foundation Year, Company Profile and etc.)

    • Table Amgen Inc Integrin Alpha 4 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Inc Integrin Alpha 4 Product and Service

    • Table Daiichi Sankyo Co Ltd (Foundation Year, Company Profile and etc.)

    • Table Daiichi Sankyo Co Ltd Integrin Alpha 4 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Daiichi Sankyo Co Ltd Integrin Alpha 4 Product and Service

    • Table Protagonist Therapeutics Inc (Foundation Year, Company Profile and etc.)

    • Table Protagonist Therapeutics Inc Integrin Alpha 4 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Protagonist Therapeutics Inc Integrin Alpha 4 Product and Service

    • Table Biogen Inc (Foundation Year, Company Profile and etc.)

    • Table Biogen Inc Integrin Alpha 4 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biogen Inc Integrin Alpha 4 Product and Service

    • Table Immunwork Inc (Foundation Year, Company Profile and etc.)

    • Table Immunwork Inc Integrin Alpha 4 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Immunwork Inc Integrin Alpha 4 Product and Service

    • Table EA Pharma Co Ltd (Foundation Year, Company Profile and etc.)

    • Table EA Pharma Co Ltd Integrin Alpha 4 Sales, Price, Value and Gross Profit (2017-2022)

    • Table EA Pharma Co Ltd Integrin Alpha 4 Product and Service

    • Table BioMAS Ltd (Foundation Year, Company Profile and etc.)

    • Table BioMAS Ltd Integrin Alpha 4 Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioMAS Ltd Integrin Alpha 4 Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.